Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

7.7K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
7.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

7.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
7.2K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

4.9K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is low a go for pediatric AML?

Blood·2026
Same author

BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia.

British journal of haematology·2026
Same author

IRS4 is a PI3K-activating cancer dependency up-regulated through DNA rearrangements or epigenetic mechanisms in multiple solid tumors.

Science advances·2026
Same author

Pharmacological inhibition of sclerostin protects bone from B-cell acute lymphoblastic leukemia-mediated destruction.

HemaSphere·2026
Same author

Myeloablative Busulfan, Fludarabine and Melphalan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myeloid Malignancy.

Asia-Pacific journal of clinical oncology·2026
Same author

Menin inhibitors display differential <i>in vitro</i> sensitivity in <i>KMT2A</i>-rearranged infant acute lymphoblastic leukemia.

Leukemia & lymphoma·2026

Related Experiment Video

Updated: Sep 23, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.4K

The Bone Marrow Microenvironment in B-Cell Development and Malignancy.

Anastasia M Hughes1,2, Vincent Kuek1,2,3, Rishi S Kotecha1,2,4,5

  • 1Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA 6009, Australia.

Cancers
|May 14, 2022
PubMed
Summary
This summary is machine-generated.

The bone marrow B-cell niche regulates normal B-cell development and can be altered by leukemia. Understanding this interaction is key to developing new therapies for B-cell precursor acute lymphoblastic leukemia.

Keywords:
B-cell acute lymphoblastic leukemia (B-ALL)B-cell developmentB-cell nichebone marrow (BM)bone marrow microenvironment (BMM)leukemia

More Related Videos

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

11.8K
Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.2K

Related Experiment Videos

Last Updated: Sep 23, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.4K
Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

11.8K
Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.2K

Area of Science:

  • Immunology
  • Hematology
  • Cancer Biology

Background:

  • B lymphopoiesis involves hematopoietic stem cells differentiating into B cells within specific bone marrow niches.
  • These niches comprise various cells that regulate B-cell progenitor proliferation and differentiation.
  • The B-cell niche is increasingly recognized for its role in B-cell precursor acute lymphoblastic leukemia (B-ALL).

Purpose of the Study:

  • To review the cellular components of bone marrow niches crucial for B lymphopoiesis.
  • To elucidate the role of the malignant B-cell niche in B-ALL development, treatment resistance, and relapse.
  • To highlight the importance of understanding leukemic cell-niche interactions for therapeutic development.

Main Methods:

  • Literature review of studies on B lymphopoiesis and the bone marrow microenvironment.
  • Analysis of research implicating the B-cell niche in B-ALL pathogenesis.
  • Synthesis of information on cell-cell crosstalk within the B-cell niche.

Main Results:

  • Bone marrow niches are essential for normal B-cell development, involving interactions between B-cell progenitors and niche cells like mesenchymal stem cells, endothelial cells, osteoblasts, osteoclasts, and adipocytes.
  • Leukemic B cells can remodel the niche to promote their survival and evade therapy.
  • The malignant B-cell niche contributes to disease progression, treatment failure, and relapse.

Conclusions:

  • The bone marrow niche plays a dual role in normal B lymphopoiesis and B-ALL.
  • Targeting the crosstalk between leukemic cells and niche components offers a promising therapeutic avenue.
  • Further research into these interactions is vital for overcoming treatment resistance and preventing relapse in B-ALL.